These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4472899)

  • 41. Serological response to rubella revaccination.
    Serdula MK; Halstead SB; Wiebenga NH; Herrmann KL
    JAMA; 1984 Apr; 251(15):1974-7. PubMed ID: 6700099
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Rubella immunity in Alsace. A study of 1026 serums by hemagglutination inhibition reaction].
    Wurtz R; Lab M; Kirn A
    Pathol Biol (Paris); 1970 Apr; 18(7):387-91. PubMed ID: 4911089
    [No Abstract]   [Full Text] [Related]  

  • 43. Rubella in an immunized island population.
    Hattis RP; Halstead SB; Herrmann KL; Witte JJ
    JAMA; 1973 Feb; 223(9):1019-21. PubMed ID: 4739294
    [No Abstract]   [Full Text] [Related]  

  • 44. [Accidental rubella vaccination in pregnancy].
    Enders G
    Dtsch Med Wochenschr; 1984 Nov; 109(47):1806-9. PubMed ID: 6499679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Persistence of antibody titers after vaccination with rubella virus vaccine ("Cendehill" strain).
    Peetermans J; du Pan RM; Huygelen C
    Dev Biol Stand; 1979; 43():361-5. PubMed ID: 520683
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chromium 51 cytotoxicity crossmatch monitoring cellular and humoral immunity in renal transplantation.
    Sterioff S; Wunderlich JR; Williams GM
    Surg Forum; 1972; 23(0):267-9. PubMed ID: 4601083
    [No Abstract]   [Full Text] [Related]  

  • 47. [Hemagglutinin of rubella virus: its characteristics and uses in epidemiology and clinical medicine].
    Grasso A; Gagnoni G; Cantagalli P; Dianzani F; Piazzi SE
    G Mal Infett Parassit; 1969 Jul; 21(7):603-15. PubMed ID: 5364953
    [No Abstract]   [Full Text] [Related]  

  • 48. Rubella epidemic in an institution: protective value of live rubella vaccine and serological behavior of vaccinated, revaccinated and naturally immune groups.
    Baba K; Yabuuchi H; Okuni H; Harima R; Minekawa Y; Taniuchi M; Otsuka T; Takahashi M; Okuno Y
    Biken J; 1978 Mar; 21(1):25-31. PubMed ID: 666723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lymphoblast proliferation and humoral antibody response after rubella vaccination.
    Lalla M; Vesikari T; Virolainen M
    Clin Exp Immunol; 1973 Oct; 15(2):193-202. PubMed ID: 4762016
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Humoral and cellular immune response of prostatic cancer patients to cytomegalovirus-related antigens.
    Sanford EJ; Geder L; Dagen JE; Laychock A; Rohner TJ; Rapp F
    J Surg Res; 1978 May; 24(5):404-8. PubMed ID: 77357
    [No Abstract]   [Full Text] [Related]  

  • 51. [Age-related differences in cellular immune response to rubella: possible implications in vaccine reactogenicity (author's transl)].
    Chiba Y; Nakao T; Ogra PL
    Uirusu; 1978 Jun; 28(1):25-30. PubMed ID: 695331
    [No Abstract]   [Full Text] [Related]  

  • 52. Cell-mediated lympholysis by human neonatal lymphocytes.
    Granberg C; Manninen K; Toivanen P
    Clin Immunol Immunopathol; 1976 Sep; 6(2):256-63. PubMed ID: 963917
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptides.
    McCarthy M; Lovett A; Kerman RH; Overstreet A; Wolinsky JS
    J Virol; 1993 Feb; 67(2):673-81. PubMed ID: 7678302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rubella-specific immune complexes after congenital infection and vaccination.
    Coyle PK; Wolinsky JS; Buimovici-Klein E; Moucha R; Cooper LZ
    Infect Immun; 1982 May; 36(2):498-503. PubMed ID: 7085069
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lymphocyte responses to rubella antigen and phytohemagglutinin after administration of the RA 27/3 strain of live attenuated rubella vaccine.
    Vesikari T; Buimovici-Klein E
    Infect Immun; 1975 Apr; 11(4):748-53. PubMed ID: 1120613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Skin test and blastogenic responses to Sporotrichun schenckii.
    Steele RW; Cannady PB; Moore WL; Gentry LO
    J Clin Invest; 1976 Jan; 57(1):156-60. PubMed ID: 1107353
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Absence of cell-mediated immunity to rubella virus 5 years after rubella vaccination.
    Rossier E; Phipps PH; Polley JR; Webb T
    Can Med Assoc J; 1977 Mar; 116(5):481-4. PubMed ID: 837312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell-mediated immune responses to the hemagglutinin and neuraminidase antigens of influenza A virus after immunization in humans.
    Chow TC; Beutner KR; Ogra PL
    Infect Immun; 1979 Jul; 25(1):103-9. PubMed ID: 478632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of cryopreserved virus-infected target cells in a lymphocytotoxicity 51Cr release microassay for cell-mediated immunity to cytomegalovirus.
    Thong YH; Hensen SA; Vincent MM; Fuccillo DA; Stiles WA; Bellanti JA
    Infect Immun; 1976 Feb; 13(2):643-5. PubMed ID: 177371
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of specific cellular and humoral immune responses in children immunized with live rubella virus vaccine.
    Steele RW; Hensen SA; Vincent MM; Fuccillo DA; Bellanti JA
    J Infect Dis; 1974 Nov; 130(5):449-53. PubMed ID: 4472899
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.